Hi Guys, Firstly, Happy Easter to those who celebrate it. As for Stamler releasing information about the study at the conference, this definitely won't happen. News like this is classified as price sensitive, and he will have to officially release it to the entire market first. Just think, you, being a long-term investor, find out Stamler just released positive information to a group of people at a particular forum, giving them a jump start on buying more stocks while the majority of the market were non the more wiser. It wouldn't be fair and could almost be classified as insider trading. The same goes the other way if heaven forbid the results were negative. Where I see us prospering from this event is brand awareness. Brand awareness in terms of our stock being picked up by retail investors, brand awareness by Big Pharma presence, brand awareness by neurologists knowing our drug exists, and prescription for patients may be possible in the short term. Momentum is key when it comes to investing. When a company starts to pique interest from investors, you see a massive momentum shift. Take our company as a prime example. a few months ago, it was languishing at the bottom of the barrel with zero interest. The ATH forum here was like a desserted ghost town. All of a sudden, after the Primate Study results, the momentum has started to shift. We started attracting new investments. Not just any investments, either. We had both retail and the big end of town show massive interest. Stock options, sophisticated and institutional investors all came to the party happy to part with some serious coin to get a slice of the action. As of this point, we are in a good place. I know what some are thinking, look at the SP. How can you say that? To that, i answered that we are fully funded until the end of our phase 2 double blinded study at years end. We have trials spread across multiple continents, we have orphan status granted by FDA and equivalent European Governing Body. No company worldwide has completed MSA/PD studies as far as we have. Primate Study results are testiment to this. We have 3, that's right 3 speakers at the most prestigious neurological forum on planet Earth. most companies can't get 1. Momentum will shift the SP north in its own time even without news. However, when news does arrive and it's positive, look out!! I personally think the next few months will prove pivitol in our momentum shift. Even more so as we get closer to November! 60 odd new MSA patients being highly dosed with ATH434 for a full year going to be epic. That's where i believe we will all see the biggest gains. As we edge closer to results being released in January, the FOMO metre will be in overdrive, and it should be a reflection of our Shareprice. That's not to say we dont potentially get bought out or at least license our drug out beforehand. It's all up in the air at the moment, but the chips shall begin to fall into place soon. GLTAH, I hope like me. You are all getting nice and plump on Easter eggs. Chocolate is my archillies heal. It will be the death of me!
Stockman
Expand
(20min delay)